Journal Report

Journal of Thrombosis and Thrombolysis

Download PDF
Journal Information
Journal Title
Journal of Thrombosis and Thrombolysis
Publisher
Springer
ISSN
0929-5305
E-ISSN
1573-742X
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
Sara R. Vazquez, Aaron S. Wilson, Daniel M. Witt
2022-10-18 Vol. 54 Issue 4 Pages 583-586
DOI: 10.1007/s11239-022-02707-4
Increased risk of venous thromboembolism among patients with familial Mediterranean fever
Omer Gendelman, Ariel J Feifel, Avishai M Tsur et al.
2022-10-14 Vol. 54 Issue 4 Pages 669-674
DOI: 10.1007/s11239-022-02711-8
Utilization trends and outcomes of catheter-directed thrombolysis for pulmonary embolism in the US by race/ethnicity
Titilope Olanipekun, Temidayo Abe, Valery Effoe et al.
2022-10-11 Vol. 54 Issue 4 Pages 675-685
DOI: 10.1007/s11239-022-02710-9
Biomarkers associated with coronary high-risk plaques
Akihiro Nakajima, Peter Libby, Satoru Mitomo et al.
2022-10-7 Vol. 54 Issue 4 Pages 647-659
DOI: 10.1007/s11239-022-02709-2
Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia
Asmaa Albuloushi, Megan Rhoten, Julie Kelly et al.
2022-9-21 Vol. 54 Issue 4 Pages 597-604
DOI: 10.1007/s11239-022-02705-6
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies
Alessandra Serrao, Francesco Malfona, Giovanni Manfredi Assanto et al.
2022-9-20 Vol. 54 Issue 4 Pages 625-629
DOI: 10.1007/s11239-022-02702-9
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
Angelo Silverio, Francesco Paolo Cancro, Marco Di Maio et al.
2022-9-20 Vol. 54 Issue 3 Pages 382-392
DOI: 10.1007/s11239-022-02701-w
Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study
Steve Deitelzweig, Xuemei Luo, Jennifer L. Nguyen et al.
2022-9-19 Vol. 54 Issue 4 Pages 696-696
DOI: 10.1007/s11239-022-02708-3
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period
Ersan Atahan, Emine Karabul, Ruveyda Akcin et al.
2022-9-19 Vol. 54 Issue 4 Pages 587-592
DOI: 10.1007/s11239-022-02703-8
Utilization of D-dimer assay, CT angiography, and the incidence of pulmonary embolism in the hospital district of Helsinki and Uusimaa (2011–2017)
Markus Sane
2022-9-18 Vol. 54 Issue 4 Pages 579-582
DOI: 10.1007/s11239-022-02698-2
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 2, 2026 04:07